Read more Discover why weight loss varies between individuals using Zepbound and how to optimize your journey
Improved Insulin Sensitivity : GLP-1 receptor agonists improve insulin sensitivity, allowing the body to use glucose more efficiently, which in turn prevents fat storage and encourages fat utilization for energy
Other side effects that may influence energy include: Hypoglycemia : Although less common with Zepbound monotherapy, low blood sugar (below 70 mg/dL) can occur, especially when combined with insulin or sulfonylureas, causing shakiness, confusion, and fatigue
According to FDA guidance, compounded medications may be appropriate when a patient's medical needs cannot be met by an FDA-approved drug, or when the approved drug is not commercially available
This dual action helps to maintain more stable blood sugar control throughout the day